IDEA: Inclusion, Diversity, Equity and Access of Underrepresented Patients to Clinical Trials

ADCs First to Cervix Cancer and Here to Stay: Understanding Provider and Patient Perspectives ISS

NRG GY018 Spotlight Interview at the 2024 SGO Annual Meeting

ENGOT-CX11 / GOG-3047 KEYNOTE A18 Spotlight Interview at the 2024 SGO Annual Meeting

IDEA Commitment Welcome & Introduction

The 3 Es of ICI in endometrial cancer:emergence, evolution, and expansion

Target Practice: Zeroing in and Eliminating Ovarian Cancer

Join the Conversation: Incorporating Breakthrough Cervical Cancer Data into Practice ISS

It’s A Whole New World: Navigating Therapeutic Options for Endometrial Cancer

Voice of The Patient Selena Rushton

The GOG Highlight Reel - Fall 2023

The Evolving Landscape in Molecular-Driven Investigational Therapies for Advanced Endometrial Cancer

Ovarian Cancer Only Symposium - Understanding Clinical Trials & The OC Roadmap

Ovarian Cancer Online Symposium: Platinum-Sensitive & Platinum-Resistant Recurrence

Kick-Off & Ovarian Cancer Overview

Low-grade serous ovarian cancer: expert consensus report on the state of the science video podcast

Uterine Cancer Awareness

ENGOT-ov60 | GOG-3052 | RAMP 201 VIDEO PODCAST

Transformative Data in Endometrial Cancer, How New Studies Will Change the Standard of Care

Novel Data in Front-line & Platinum Sensitive Disease

Last Words and Wrap Up

Emerging Opportunities in Cervical Cancer

Emerging opportunities in platinum-resistant recurrent ovarian cancer

Mirvetuximab Soravtansine: The SORAYA & MIRASOL Studies. The future of Targeting FRα

Welcome & Introductions

It takes a village: Interdisciplinary management of patients with advanced cervical cancer Symposium

Dr. Cloven & Morgan Newman Cervical Cancer Awareness Month Interview

GCAM Recording, Dr Gardner & Susan Leighton

GOG-3052 | ENGOT-ov60 CLINICAL TRIAL REVIEW

Accrual Culture 2021 Endometrial Portfolio Year End Review